Advertisement
Home »

Early Post-Op Vedolizumab Decreases Endoscopic Relapse in CD

Mar 14, 2023

REFERENCES & ADDITIONAL READING

D’Haens G. Prevention of postoperative recurrence of Crohn’s disease with vedolizumab: First results of the prospective placebo-controlled randomized trial REPREVIO. OP14, ECCO 2023, 1–4 March, Copenhagen, Denmark.

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

RELEVANT ARTICLES FOR YOU

Advertisement